STAT Podcast: Trump Letter, Lilly Obesity Pill Approval
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- STAT aired its weekly biotech podcast “The Readout LOUD,” covering FDA regulatory flexibility and other topics.
- Rod Wong joined the episode to discuss an industry‑patient coalition’s letter to President Trump requesting more FDA flexibility.
- Eli Lilly’s obesity pill received U.S. FDA approval, which the episode highlighted.
- YouTube was cited as a platform where psychedelic drug promotion was occurring.
- Apple Podcasts and Spotify host the episode for streaming.
Why it matters: Biotech investors see the coalition’s letter to President Trump as a push for FDA regulatory flexibility, aiming to speed rare‑disease drug approvals and influence investment trends, while the FDA’s approval of Eli Lilly’s obesity pill introduces a new treatment option for obesity.
Ask SkimNews
